Its board also recently changed with the controversial election of one new member and the departure of three others who chose not to run for reelection. Some analysts argue that Biogen was hindered in its ability to pursue business development because of board infighting. The recent board and executive team changes may suggest the company is becoming more harmonious analysts have speculated